Results 211 to 220 of about 36,206 (272)

The manipulator behind "Scissors": γ -secretase and its modulators in Alzheimer's disease. [PDF]

Front Aging Neurosci
Ning G, Fan X, Juan D, Wenxue Z, Sijia W, Meinei C, Xiaolong D, Yiming Q.   +7 more
europepmc   +1 more source

Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets. [PDF]

CNS Neurosci Ther
Ahmadi S, Khaledi S, Ahmadi K, Hassanzadeh K.   +3 more
europepmc   +1 more source

Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PDF]

Front Aging Neurosci
Alhusaini M, Mussa BM, Ilce BY, Alhaj H, Hamoudi R.   +4 more
europepmc   +1 more source

Repurposing FDA-approved drugs as multi-target neuroprotective agents for Alzheimer's disease via computational screening and experimental validation. [PDF]

Sci Rep
Phemphunananchai K, Waiwut P, Phetcharaburanin J, Poonsawas P, Boonyarat C.   +4 more
europepmc   +1 more source

The therapeutic potential of beta-carotene against neuroinflammation and amyloid beta in SH-SY5Y cells. [PDF]

Sci Rep
Khan MI, Jeong ES, Tasreen G, Khan MZ, Shin JH, Kim JD.   +5 more
europepmc   +1 more source

RNA-binding activity of PHGDH drives amyloid-beta production in a human brain organoid model of sporadic Alzheimer's disease. [PDF]

Proc Natl Acad Sci U S A
Chen J, Xu M, Liu Y, Hadi F, Xue S, Chien S, Zhong S.   +6 more
europepmc   +1 more source

Blood level of β-amyloid, Tau, and p-Tau in mild cognitive impairment and Alzheimer disease: A follow up study. [PDF]

Indian J Med Res
Pradhan R, Kumari S, Singh AK, Rao AR, Yadav Y, Upadhyay AD, Mehta PK, Dey AB, Dey S.   +8 more
europepmc   +1 more source

Toward a Unified Framework in Molecular Neurobiology of Alzheimer's Disease: Revisiting the Pathophysiological Hypotheses. [PDF]

Mol Neurobiol
Hein ZM, Karikalan B, Gopalakrishna PK, Dhevi K, Alkatiri A, Hussan F, Mohd Moklas MA, Jagadeesan S, Che Ramli MD, Che Mohd Nassir CMN, Vishnumukkala T.   +10 more
europepmc   +1 more source